OlympiAD: Olaparib Captures Gold for BRCA Breast Cancer

Study author Dr Susan Domchek discusses the positive results of the OlympiAD trial, presented at the ASCO plenary session, indicating olaparib as a strong option in metastatic breast cancer.

Source: Medscape Oncology - June 12, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts